HOWL – werewolf therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Form SC 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 10-Q Werewolf Therapeutics, For: Mar 31
Form 8-K Werewolf Therapeutics, For: May 03
Form ARS Werewolf Therapeutics, For: Dec 31
Form DEFA14A Werewolf Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.